Fonds Clinatec
The Fonds Clinatec is an endowment fund that supports and accelerates research at the intersection of technology and medicine.
The CEA, a leading government research organization based in France, set up Fonds Clinatec in 2014 to raise the substantial resources required to respond to growing health-related needs. The independent endowment manages its own partnership agreements with institutions like the CEA, Université Grenoble Alpes, and Grenoble University Medical center. Fonds Clinatec has done significant fundraising in the private sector, allocating the funds to Clinatec’s most groundbreaking programs.
In 2019, Fonds Clinatec became a research organization in its own right so that it could conduct its own research with its own teams, in addition to raising and redistributing funds.
The purpose of this transformation was to make the organization even more agile. As a nonprofit with a public interest mission, the Clinatec endowment fund makes new scientific knowledge and research results freely available. The fund’s priority is to bring new advances in treatment to as many patients as possible.
Our cause
We believe that technological and biomedical innovations are the future of patient care.
Our objective is to put a new generation of solutions in the hands of expert clinicians so that they can better respond to the needs of growing numbers of patients.
Values
Ethics
Patients are at the center of the Clinatec endowment fund’s efforts to improve quality of life and reduce dependency.
Cooperation
One of the Clinatec endowment fund’s strengths is its multidisciplinary expertise, cooperation with scientists from around the globe, and partnerships with a variety of healthcare stakeholders.
Scientific excellence
What makes the projects at Clinatec so unique is the high level of engagement of our scientists, their internationally-recognized research, and their unwavering commitment to making an impact on society.
Key figures
Founding partners of the Clinatec biomedical research center
with the Clinatec endowment fund
The French Alternative Energies and Atomic Energy Commission (CEA)
is a major research and technology organization (RTO) in service to government, citizens, and the economy. The CEA’s mission is to build tomorrow’s society today through research on micro- and nanoelectronics, new energy technology, and medical technology.
Grenoble University Medical Center
is the leading hospital in the French Alps, a region that is home to two million people. Its missions are patient care, teaching, research, and prevention.
Université Grenoble Alpes
is home to 62,000 undergraduate and graduate students, 3,700 doctoral students, and 7,000 faculty members. This major university is committed to innovation in teaching and cross-disciplinarity in both research and academics.
“Fonds Clinatec's corporate sponsors and individual donors are committed to providing the research funding needed to develop innovative therapies for patients with diseases for which there is currently no effective treatment or cure.”
Board of Directors
Determines the Clinatec endowment fund’s strategy and policies. Responsible for long-term strategic alignment.
- Jean-Philippe Bourgoin, Board of Directors Chairman, Clinatec endowment fund & Deputy Director, CEA Technology Research Division
- Sophie Cluzel, Chairwoman, Clinatec endowment fund. Former minister for the Disabled
- Sébastien Dauvé, CEO, CEA-Leti
- Geneviève Fioraso, Former Minister of Education and Research & former French National Assemblywoman for Isère
- Delphine Geny-Stephann, Managing Director, GINKO
- Paul Jacques, Scientific Advisor to the CEA Director of Technology Research
- Guy Janet-Maitre, Regional Representative (Savoie), France Parkinson
- Jean-Pierre Maureau, President, Académie de comptabilité
- Frédéric Salat-Baroux, Attorney at Weil, Gotshal & Manges
- André Syrota, Advisor to the CEA General Administrator & Professor Emeritus, Université Paris-Saclay
- Jean-Philippe Bourgoin, Board of Directors Chairman, Clinatec endowment fund & Deputy Director, CEA Technology Research Division
- Sophie Cluzel, Chairwoman, Clinatec endowment fund. Former minister for the Disabled
- Sébastien Dauvé, CEO, CEA-Leti
- Geneviève Fioraso, Former Minister of Education and Research & former French National Assemblywoman for Isère
- Delphine Geny-Stephann, Managing Director, GINKO
- Paul Jacques, Scientific Advisor to the CEA Director of Technology Research
- Guy Janet-Maitre, Regional Representative (Savoie), France Parkinson
- Jean-Pierre Maureau, President, Académie de comptabilité
- Frédéric Salat-Baroux, Attorney at Weil, Gotshal & Manges
- André Syrota, Advisor to the CEA General Administrator & Professor Emeritus, Université Paris-Saclay
Scientific Advisory Board, Neuroscience
Advises the organization on potential research avenues, helps assess projects, and provides insights into research partnerships.
- Dr Luc Buée, Research scientist, Lille, France
- Pr Pierre Burbaud, Neurologist, Bordeaux, France
- Dr Olivier David, Research scientist, Grenoble, France
- Dr Giorgio Lo Russo, Neurosurgeon, Milan, Italy
- Dr Andres Lozano, Neurosurgeon, Toronto, Canada
- Pr Pierre Magistretti, Research scientist, Lausanne, Switzeralnd (international advisor and coordinator of the Scientific Committee)
- Pr André Niéoullon, Research scientist, Marseille, France
- Pr Stéphane Palfi, Neurosurgeon, Créteil, France
- Pr Jean-Marc Régis, Neurosurgeon, Marseille, France
- Dr Luc Buée, Research scientist, Lille, France
- Pr Pierre Burbaud, Neurologist, Bordeaux, France
- Dr Olivier David, Research scientist, Grenoble, France
- Dr Giorgio Lo Russo, Neurosurgeon, Milan, Italy
- Dr Andres Lozano, Neurosurgeon, Toronto, Canada
- Pr Pierre Magistretti, Research scientist, Lausanne, Switzeralnd (international advisor and coordinator of the Scientific Committee)
- Pr André Niéoullon, Research scientist, Marseille, France
- Pr Stéphane Palfi, Neurosurgeon, Créteil, France
- Pr Jean-Marc Régis, Neurosurgeon, Marseille, France